We are live on ! Find out more
ICRM

Insight Capital Research & Management Portfolio holdings

AUM $177M
1-Year Est. Return 72%
This Fund
S&P 500
This Quarter Est. Return
+10.67%
1 Year Est. Return
+72%
3 Year Est. Return
+286.87%
5 Year Est. Return
10 Year Est. Return
AUM
$378M
AUM Growth
-$21.5M
Cap. Flow
-$42.5M
Cap. Flow %
-11.24%
Top 10 Hldgs %
21.97%
Holding
153
New
39
Increased
15
Reduced
41
Closed
55

Top Sells

Rank Stock Value
1
JBLU icon
JetBlue
JBLU
+$12.4M
2
SMCI icon
Super Micro Computer
SMCI
+$9.33M
3
HNT
HEALTH NET INC
HNT
+$7.42M
4
TNET icon
TriNet
TNET
+$6.8M
5
STE icon
Steris
STE
+$6.7M

Sector Composition

Rank Sector Weight
1 Technology 26.42%
2 Healthcare 18.05%
3 Consumer Discretionary 17.58%
4 Industrials 9.97%
5 Communication Services 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
76
Oracle
ORCL
$418B
$1.94M 0.51%
48,106
-203
-0.4% -$8.8K
ULTA icon
77
Ulta Beauty
ULTA
$23.2B
$1.72M 0.46%
+11,147
New +$1.71M
VRSK icon
78
Verisk Analytics
VRSK
$24.6B
$1.7M 0.45%
+23,362
New +$1.72M
IBM icon
79
IBM
IBM
$220B
$1.68M 0.44%
+10,822
New +$1.74M
CHKP icon
80
Check Point Software Technologies
CHKP
$12.9B
$1.55M 0.41%
+19,532
New +$1.65M
TGT icon
81
Target
TGT
$66.5B
$1.27M 0.33%
15,511
-33,580
-68% -$2.72M
SLB icon
82
SLB Ltd
SLB
$76.4B
$1.09M 0.29%
12,656
+289
+2% +$26.1K
RTX icon
83
RTX Corp
RTX
$299B
$876K 0.23%
12,552
-76
-0.6% -$5.58K
MIDD icon
84
Middleby
MIDD
$6.09B
$871K 0.23%
7,763
+278
+4% +$29.7K
MMM icon
85
3M
MMM
$93.2B
$862K 0.23%
6,684
-46
-0.7% -$6.17K
HZNP
86
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$847K 0.22%
+24,395
New +$744K
AOS icon
87
A.O. Smith
AOS
$8.63B
$819K 0.22%
+22,750
New +$784K
CRI icon
88
Carter's
CRI
$1.48B
$790K 0.21%
7,430
+254
+4% +$25.5K
IFF icon
89
International Flavors & Fragrances
IFF
$21.7B
$768K 0.2%
7,026
-543
-7% -$62.7K
ORLY icon
90
O'Reilly Automotive
ORLY
$75.4B
$753K 0.2%
+49,980
New +$741K
RSP icon
91
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$673K 0.18%
8,428
QRVO icon
92
Qorvo
QRVO
$8.45B
$663K 0.18%
8,258
-37,694
-82% -$2.92M
IBB icon
93
iShares Biotechnology ETF
IBB
$9.68B
$483K 0.13%
3,930
FXH icon
94
First Trust Health Care AlphaDEX Fund
FXH
$1.07B
$382K 0.1%
5,554
MSCI icon
95
MSCI
MSCI
$41.3B
$370K 0.1%
6,014
-476
-7% -$29.5K
MKTX icon
96
MarketAxess Holdings
MKTX
$5.72B
$248K 0.07%
2,669
-100
-4% -$8.82K
MD icon
97
Pediatrix Medical
MD
$2.19B
$205K 0.05%
2,760
-99
-3% -$7.13K
INTU icon
98
Intuit
INTU
$89.1B
$203K 0.05%
2,013
-95
-5% -$9.7K
ADEA icon
99
Adeia
ADEA
$3.17B
-327,582
Closed -$3.49M
AMGN icon
100
Amgen
AMGN
$219B
-12,438
Closed -$1.99M

Similar funds

Insight Capital Research & Management's Q2 2015 Portfolio in Review

As of Q2 2015, Insight Capital Research & Management held 153 positions worth $378M, down 5.4% from $400M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Insight Capital Research & Management withdrew a net $42.5M in Q2 2015, closing 55 positions and reducing 41 holdings. Its most notable exit was JetBlue, an estimated $12.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Insight Capital Research & Management opened a new position in Cynosure, Inc. Class A worth $8.1M.

  • Insight Capital Research & Management's largest Q2 2015 buy was Cynosure, Inc. Class A: 209,899 shares worth $8.1M.
  • Insight Capital Research & Management added most to Amazon in Q2 2015, an estimated $6M increase.
  • Insight Capital Research & Management's biggest Q2 2015 reduction was NXP Semiconductors, cutting an estimated $5.3M.
  • Insight Capital Research & Management fully exited JetBlue in Q2 2015, selling an estimated $12.4M.
  • Insight Capital Research & Management's ten largest holdings make up 22% of its $378M portfolio in Q2 2015.
  • Insight Capital Research & Management opened 39 new positions and closed 55 in Q2 2015.
  • Insight Capital Research & Management's portfolio value fell 5.4% quarter-over-quarter to $378M.

Based on Insight Capital Research & Management's 13F filing for Q2 2015, filed 13 Aug 2015.